Advertisement
Advertisement
U.S. markets open in 1 hour 58 minutes
Advertisement
Advertisement
Advertisement
Advertisement

GBS Inc. (GBS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.6800+0.1100 (+7.01%)
At close: 04:00PM EST
1.7500 +0.07 (+4.17%)
Pre-Market: 07:00AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close1.5700
Open1.6200
Bid0.0000 x 900
Ask0.0000 x 900
Day's Range1.6005 - 1.7400
52 Week Range1.5100 - 14.2400
Volume241,561
Avg. Volume887,263
Market Cap25.003M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for GBS

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • GBS Inc.
    Daily – Vickers Top Buyers & Sellers for 10/27/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    last monthArgus Research
View more
  • Benzinga

    21 Stocks Moving in Wednesday's Pre-Market Session

    Gainers GBS Inc. (NASDAQ: GBS) rose 72.3% to $5.58 in pre-market trading. The company markets saliva test for diabetes management and previously announced collaboration on covid-19 diagnostic with Harvard's Wyss Institute. Field Trip Health Ltd. (NASDAQ: FTRP) shares rose 30% to $6.25 in pre-market trading. HC Wainwright & Co. initiated coverage on Field Trip Health with a Buy rating and announced a price target of $20. Focus Universal Inc. (NASDAQ: FCUV) rose 25.1% to $6.38 in pre-market tradin

  • Benzinga

    Point of Care Testing Company GBS Develops Technology to Take the Fear out of Diabetes and COVID Testing

    GBS Inc. is presenting at the Benzinga Healthcare Small Cap Conference on September 29, 2021. For some people with diabetes, testing with a pinprick is no more than a minor inconvenience. But for many adults with testing phobias, they not only face the possibility of a rapid heartbeat or even passing out but could also skip much-needed glucose testing, putting their lives at risk. GBS Inc. (NASDAQ: GBS) understands that testing anxiety can be a life-or-death dilemma and is on a mission to develo

  • Simply Wall St.

    Is GBS (NASDAQ:GBS) In A Good Position To Invest In Growth?

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Advertisement
Advertisement